Verano Holdings (VRNO) EBT (2021 - 2026)
Verano Holdings (VRNO) posted quarterly EBT of -$6.2 million for Q1 2026, down 206.27% year-over-year from $5.8 million in Q1 2025, and up 96.41% quarter-over-quarter from -$172.7 million in Q4 2025.
Verano Holdings (VRNO) EBT (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported EBT for 6 consecutive years, with -$6.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 206.27% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$178.3 million (up 40.72% YoY), while the FY2025 annual figure was -$166.2 million, up 44.57% from the prior year.
- EBT grew to -$6.2 million in Q1 2026 per VRNO's latest filing, from -$172.7 million in the prior quarter.
- Across five years, EBT topped out at $27.0 million in Q3 2023 and bottomed at -$318.2 million in Q4 2024.
- Historically, EBT has averaged -$35.8 million across 5 years, with a median of $5.8 million in 2025.
- Annual changes were most pronounced in 2023 — EBT soared 1063.85% — and 2024, when it tumbled 866.26%.
- Verano Holdings' EBT stood at -$216.6 million in 2022, then surged by 84.8% to -$32.9 million in 2023, then sank by 866.26% to -$318.2 million in 2024, then soared by 45.74% to -$172.7 million in 2025, then soared by 96.41% to -$6.2 million in 2026.
- Business Quant data shows VRNO's EBT at -$6.2 million in Q1 2026, -$172.7 million in Q4 2025, and -$15.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Verano Holdings | 445.39 Mn | 360.20 Mn | 99.70 Mn | -10.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.49 Mn |
| Mar 31, 2026 | -6.20 Mn |
| Dec 31, 2025 | -172.68 Mn |
| Sep 30, 2025 | -15.39 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -318.25 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 8.77 Mn |
| Mar 31, 2024 | 6.66 Mn |
| Dec 31, 2023 | -32.94 Mn |
| Sep 30, 2023 | 27.03 Mn |
| Jun 30, 2023 | 14.62 Mn |
| Mar 31, 2023 | 19.08 Mn |
| Dec 31, 2022 | -216.64 Mn |
| Sep 30, 2022 | 26.39 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 25.59 Mn |
| Dec 31, 2021 | 30.22 Mn |
| Sep 30, 2021 | 15.12 Mn |